Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results-Reference-Cited by-同舟云学术

Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results

Published:2015-03-14 Issue:11 Volume:33 Page:1707-1714
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Tewes Susanne,Hueper Katja,Hartung Dagmar,Imkamp Florian,Herrmann Thomas R. W.,Weidemann Juergen,Renckly Stefan,Kuczyk Markus A.,Wacker Frank,Peters Inga

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-015-1525-4.pdf

Reference30 articles.

1. Gosselaar C, Roobol MJ, van den Bergh RC, Wolters T, Schroder FH (2009) Digital rectal examination and the diagnosis of prostate cancer–a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam. Eur Urol 55(1):139–146. doi: 10.1016/j.eururo.2008.03.079

2. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC Jr, Group SDS (2007) Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 69(3):495–499. doi: 10.1016/j.urology.2006.10.036

3. Suardi N, Capitanio U, Chun FK, Graefen M, Perrotte P, Schlomm T, Haese A, Huland H, Erbersdobler A, Montorsi F, Karakiewicz PI (2008) Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 113(8):2068–2072. doi: 10.1002/cncr.23827

4. Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63(2):214–230. doi: 10.1016/j.eururo.2012.09.033

5. Djavan BOB, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, Seitz C, Susani M, Borkowski A, Boccon-Gibod L, Schulman CC, Marberger M (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166(5):1679–1683. doi: 10.1016/S0022-5347(05)65652-2

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer;The Prostate;2023-12-27

2. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-09

3. Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database;World Journal of Urology;2022-09-23

4. Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer;Frontiers in Oncology;2022-06-27

5. Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series;The Prostate;2022-05-10